Cargando…
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
Inflammatory bowel disease is an autoimmune disease that causes chronic inflammation of the gastrointestinal tract. Endothelial dysfunction, defined by a reduced endothelial barrier and an increase in the expression of adhesion molecules, is part of the pathology of inflammatory bowel disease. In th...
Autores principales: | Kim, Ye-Seul, Zhang, Haiying, Lee, Sunghye, Park, Songyi, Noh, Minyoung, Kim, Young-Myeong, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523507/ https://www.ncbi.nlm.nih.gov/pubmed/33041812 http://dx.doi.org/10.3389/fphar.2020.571266 |
Ejemplares similares
-
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
por: Kim, Yeomyeong, et al.
Publicado: (2023) -
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
por: Kim, Hyejeong, et al.
Publicado: (2023) -
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells
por: Park, Songyi, et al.
Publicado: (2021) -
CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome
por: Park, Songyi, et al.
Publicado: (2023) -
CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury
por: Kim, Dong Young, et al.
Publicado: (2020)